Prospects for Development of Induced Pluripotent Stem Cell‑Derived CAR‑Targeted Immunotherapies

Medicine and Dentistry

• Cancer Therapy 50%
• Drug 50%
• Ex Vivo 50%
• Hematologic Malignancy 50%
• Medicine 50%
• Neoplasm 50%
• Patient 50%
• Personalized Medicine 50%
• Reproducibility 50%
• Solid Malignant Neoplasm 50%
• T Cell 50%
• Therapeutics 50%

Biochemistry, Genetics and Molecular Biology

• Gene 50%
• Induced Pluripotent Stem Cell 100%
• Solid 50%